Mutations in Ribosomal Protein L16 Conferring Reduced Susceptibility to Evernimicin (SCH27899): Implications for Mechanism of Action

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.44.3.732-738.2000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search